Goldman Sachs Group Inc Novo Nordisk A S Transaction History

Goldman Sachs Group Inc

$555 Billion
Q1 2024

A detailed history of Goldman Sachs Group Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Goldman Sachs Group Inc holds 5,161,051 shares of NVO stock, worth $698 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

5,161,051

Previous 4,627,335 11.53%

Holding current value

$698 Million

Previous $479 Million 38.43%

% of portfolio

0.12%

Previous 0.09%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $54.5 Million - $72.5 Million	533,716 Added 11.53%	5,161,051 $663 Million
Q4 2023 Feb 13, 2024	BUY	$87.78 - $105.45 $30.3 Million - $36.4 Million	345,332 Added 8.06%	4,627,335 $479 Million
Q3 2023 May 14, 2024	SELL	$90.94 - $199.54 $31.4 Million - $68.9 Million	-345,332 Reduced 7.46%	4,282,003 $389 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $220 Million - $484 Million	2,423,736 Added 130.43%	4,282,003 $389 Million
Q2 2023 May 14, 2024	SELL	$155.98 - $172.65 $5.32 Million - $5.88 Million	-34,079 Reduced 1.8%	1,858,267 $301 Million

Q2 2023 Aug 14, 2023	SELL	$155.98 - $172.65 $5.32 Million - $5.88 Million	-34,079 Reduced 1.8%	1,858,267 $301 Million
Q1 2023 May 14, 2024	SELL	$132.34 - $159.14 $1.64 Million - $1.97 Million	-12,396 Reduced 0.65%	1,892,346 $301 Million
Q1 2023 May 11, 2023	SELL	$132.34 - $159.14 $1.64 Million - $1.97 Million	-12,396 Reduced 0.65%	1,892,346 $301 Million
Q4 2022 May 14, 2024	BUY	$102.55 - $135.33 $2.05 Million - $2.7 Million	19,969 Added 1.06%	1,904,742 $258 Million
Q4 2022 Feb 13, 2023	BUY	$102.55 - $135.33 $2.05 Million - $2.7 Million	19,969 Added 1.06%	1,904,742 $258 Million
Q3 2022 May 14, 2024	BUY	$95.28 - $116.93 $9.35 Million - $11.5 Million	98,129 Added 5.49%	1,884,773 $188 Million
Q3 2022 Nov 10, 2022	BUY	$95.28 - $116.93 $9.35 Million - $11.5 Million	98,129 Added 5.49%	1,884,773 $188 Million
Q2 2022 May 14, 2024	SELL	$103.24 - $121.81 $293 Million - $346 Million	-2,840,691 Reduced 61.39%	1,786,644 $199 Million
Q2 2022 Aug 15, 2022	BUY	$103.24 - $121.81 $8.23 Million - $9.71 Million	79,734 Added 4.67%	1,786,644 $199 Million
Q1 2022 May 16, 2022	BUY	$93.1 - $112.54 $16.4 Million - $19.8 Million	175,732 Added 11.48%	1,706,910 $190 Million
Q4 2021 Feb 14, 2022	SELL	$95.88 - $117.08 $11.6 Million - $14.2 Million	-120,913 Reduced 7.32%	1,531,178 $171 Million
Q3 2021 Nov 10, 2021	BUY	$84.42 - $106.62 $139 Million - $176 Million	1,652,091 New	1,652,091 $159 Million

Others Institutions Holding NVO

# of Institutions

1,851

Shares Held

309M

Call Options Held

5.29M

Put Options Held

4.93M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $305B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Novo Nordisk A S Transaction History